Skip to content

A post market registry to understand the his bundle pacing (HBP) workflow in routine practice.

His Bundle Pacing Registry - HBP Registry

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/04/018796
Enrollment
1000
Registered
2019-04-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I440- Atrioventricular block, first degree Health Condition 2: I501- Left ventricular failure, unspecified

Interventions

Intervention1: Permanent HBP lead and an Abbott pacemaker or defibrillator or CRT-P/D.: - To characterize the workflow associated with the HBP device implants and follow-up - To quantify the clinical

Sponsors

St Jude Medical India Pvt Ltd Abbott
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects must meet the following inclusion criteria for enrollment in the registry. 1. Scheduled for implantation of a de novo Abbott pacemaker, defibrillator, or CRT-P/D device with a pacing lead located at the His bundle according to the clinical siteâ??s routine care 2. At least 18 years of age 3. Willing and able to comply with the prescribed follow-up tests and schedule of evaluations 4. Provided written informed consent prior to any registry-related procedures

Exclusion criteria

Exclusion criteria: Subjects will be excluded from enrollment if any of the exclusion criteria is met below. 1. History of tricuspid valve repair or replacement 2. Currently participating in another clinical study with an active treatment arm and belong to the active arm 3. Presence of other anatomic or comorbid conditions, or other medical, social, or psychological conditions that, in the investigatorâ??s opinion, could limit the subjectâ??s ability to participate in the registry or to comply with follow-up requirements, or impact the scientific soundness of the registry results 4. Previous failed HBP implant 5. Life expectancy of less than 6 months 6. Known contraindication for an HBP implant (i.e. ongoing infection, known inclusion of the subclavian vein, etc.)

Design outcomes

Primary

MeasureTime frame
Implant and follow-up characteristics will be compared with and without utilizing the EnSite Cardiac Mapping System during HBP device implants.Timepoint: Implant and 6-Month Follow-Up

Secondary

MeasureTime frame
Not ApplicableTimepoint: Not Applicable

Countries

Czech Republic, France, Germany, India, Spain, United States of America

Contacts

Public ContactDr Sumit Anand

St. Jude Medical India Pvt. Ltd.(Abbott)

sumit.anand@abbott.com01142600155

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026